NFA
IPXL

Nationwide Fund Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Nationwide Fund Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-76,769
Closed -$1.56M – 2972
2017
Q3 		$1.56M Buy
76,769
+28,830
+60% +$551K 0.01% 1560
2017
Q2 		$772K Sell
47,939
-3,735
-7% -$55.2K ﹤0.01% 1936
2017
Q1 		$654K Sell
51,674
-3,577
-6% -$43.2K ﹤0.01% 2012
2016
Q4 		$732K Buy
55,251
+3,350
+6% +$57.3K ﹤0.01% 1953
2016
Q3 		$1.23M Sell
51,901
-400
-0.8% -$10.8K 0.01% 1647
2016
Q2 		$1.51M Sell
52,301
-4,620
-8% -$151K 0.01% 1504
2016
Q1 		$1.84M Sell
56,921
-753
-1% -$26.5K 0.01% 1387
2015
Q4 		$2.47M Buy
57,674
+793
+1% +$31.7K 0.01% 1263
2015
Q3 		$2M Sell
56,881
-3,794
-6% -$171K 0.01% 1360
2015
Q2 		$2.79M Sell
60,675
-13,253
-18% -$629K 0.01% 1260
2015
Q1 		$3.46M Sell
73,928
-7,418
-9% -$295K 0.01% 1164
2014
Q4 		$2.58M Sell
81,346
-11,998
-13% -$351K 0.01% 1283
2014
Q3 		$2.21M Sell
93,344
-15,730
-14% -$403K 0.01% 1384
2014
Q2 		$3.27M Buy
109,074
+34,888
+47% +$941K 0.01% 1216
2014
Q1 		$1.96M Sell
74,186
-123,893
-63% -$3.1M 0.01% 1362
2013
Q4 		$4.98M Buy
198,079
+3,339
+2% +$74.5K 0.02% 951
2013
Q3 		$3.99M Buy
194,740
+82,191
+73% +$1.7M 0.02% 1031
2013
Q2 		$2.25M Buy
+112,549
New +$2M 0.01% 1230

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nationwide Fund Advisors's IPXL Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 76,769 shares — an estimated $1.56M sold.

Nationwide Fund Advisors first reported a position in IPXL in Q2 2013 and held it in 18 quarters. The position peaked at $4.98M in Q4 2013. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 76,769 Impax Laboratories, Inc. shares in Q4 2017, an estimated $1.56M.
  • Nationwide Fund Advisors first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Impax Laboratories, Inc. position peaked at $4.98M in Q4 2013.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.